Literature DB >> 24046289

CDC calls for urgent action to combat rise of drug resistant pathogens.

Michael McCarthy1.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24046289     DOI： 10.1136/bmj.f5649

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Linker Editing of Pneumococcal Lysin ClyJ Conveys Improved Bactericidal Activity.

Authors:  Hang Yang; Dehua Luo; Irina Etobayeva; Xiaohong Li; Yujing Gong; Shujuan Wang; Qiong Li; Poshi Xu; Wen Yin; Jin He; Daniel C Nelson; Hongping Wei
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

2.  ClyJ Is a Novel Pneumococcal Chimeric Lysin with a Cysteine- and Histidine-Dependent Amidohydrolase/Peptidase Catalytic Domain.

Authors:  Hang Yang; Yujing Gong; Huaidong Zhang; Irina Etobayeva; Paulina Miernikiewicz; Dehua Luo; Xiaohong Li; Xiaoxu Zhang; Krystyna Dąbrowska; Daniel C Nelson; Jin He; Hongping Wei
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

3.  A genomic approach to understand interactions between Streptococcus pneumoniae and its bacteriophages.

Authors:  Philippe Leprohon; Hélène Gingras; Siham Ouennane; Sylvain Moineau; Marc Ouellette
Journal:  BMC Genomics       Date:  2015-11-18       Impact factor: 3.969

4.  Auranofin-loaded nanoparticles as a new therapeutic tool to fight streptococcal infections.

Authors:  Roberto Díez-Martínez; Esther García-Fernández; Miguel Manzano; Ángel Martínez; Mirian Domenech; María Vallet-Regí; Pedro García
Journal:  Sci Rep       Date:  2016-01-18       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.